The subtle differences between VCTs and EIS

  • Communicate the differences between EIS and VCT investing
  • Explain what to look out for in either investment
  • Identify opportunities in EIS and VCT investing
  • Communicate the differences between EIS and VCT investing
  • Explain what to look out for in either investment
  • Identify opportunities in EIS and VCT investing
pfs-logo
cisi-logo
CPD
Approx.30min
pfs-logo
cisi-logo
CPD
Approx.30min
twitter-iconfacebook-iconlinkedin-iconmail-iconprint-icon
Search supported by
pfs-logo
cisi-logo
CPD
Approx.30min
The subtle differences between VCTs and EIS
VCTs and EIS offer different benefits, but both can play a role in tax planning. (Photo: Bloomberg)

By comparison, the “patient capital” approach within some EIS offers, which focus on early-stage and start-up investments, is known to be approaching 10 years or more, with little sign of anything coming to fruition for investors.

In fact, recent research by independent reviewer Micap suggested that only three or four EIS managers out of circa 50 have ever returned more than 50 per cent of the funds they had raised into their schemes to investors, which is a damning statistic.

The positive impact of 30 per cent initial tax relief might be called into question if it is viewed over a 10-year period. 

Further consideration

This provokes a further and crucial element for advisers and investors to consider. The majority of EIS information memoranda attract money based on the strength of investment teams, sector specialism, hands-on involvement with investees, and geographic spread and presence.

Most invest in private companies and two specialise in Aim-only EIS structures. 

Invariably, the aforementioned memoranda will point their investors towards an exit, hopefully a profitable one via a trade sale or initial public offering of their investees.

Here is another issue for investors to consider. Several years ago investment time horizons were often pitched at four or five years, whereas risk to capital conditions in recent years have seen this stretch to five to seven years or more.

The reality of a trade sale or IPO when investing in an early-stage company within a five to seven-year period is dubious, with very few achieving such a milestone.

Understanding the exit track record of the manager is imperative

In addition to those invested in private companies, Aim-only EIS portfolios are also available.  

These generally involve backing later-stage or more mature companies if only by virtue of being on the Aim. These companies also have access more readily to follow-on funding by virtue of their access to the public markets, meaning that out and out failures that result in a full loss of capital are rarer.

While daily market price volatility may appeal to some more than others, market liquidity should allow exits within a much shorter timeframe.

Valuations

The subject of valuations by those EIS managers running investments in private companies requires investor attention. If investment time horizons are indeed stretching out, then valuations and reporting of them assume greater significance.

Holding valuations “at cost” is often a default position, but is it really credible four or five years into an investment to suggest that nothing has got better or worse over that time period?  

If the information memoranda are to hold good, then investors would normally expect positive developments that point to a trade sale or IPO.

PAGE 2 OF 4